10-Q: Phreesia Reports Strong Q2 Growth, Returns to Profitability

Phreesia, Inc. announced robust financial results for the second quarter, achieving net income and significant growth in revenue and Adjusted EBITDA, alongside a strategic acquisition.

Summary

• Total revenue increased by 15% to $117.3 million for the three months ended July 31, 2025, compared to $102.1 million in the prior year.
• The company reported net income of $0.7 million for the three months ended July 31, 2025, a significant improvement from a net loss of $18.0 million in the same period last year.
• Adjusted EBITDA surged by 240% to $22.1 million for the three months ended July 31, 2025, up from $6.5 million in the prior year.
• Free cash flow increased by 160% to $9.6 million for the three months ended July 31, 2025, compared to $3.7 million in the same period last year.
• For the six months ended July 31, 2025, total revenue grew 15% to $233.2 million, and net loss significantly narrowed to $3.3 million from $37.7 million.
• Adjusted EBITDA for the six months ended July 31, 2025, was $42.9 million, a 305% increase from $10.6 million in the prior year.
• Free cash flow for the six months ended July 31, 2025, turned positive at $17.1 million, compared to a negative $2.5 million in the prior year.
• Average number of healthcare services clients (AHSCs) grew to 4,467 for the three months ended July 31, 2025, from 4,169 in the prior year.
• Total revenue per AHSC increased by 7% to $26,249 for the three months ended July 31, 2025.
• Patient payment volume rose to $1,250 million for the three months ended July 31, 2025, from $1,093 million in the prior year.
• The company announced a definitive agreement to acquire AccessOne Parent Holdings, Inc. for $160 million in cash, expected to close in Q3 or early Q4 of fiscal year 2026.

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to the significant financial turnaround, strong revenue growth, and substantial improvements in profitability metrics (net income, Adjusted EBITDA, free cash flow). The strategic acquisition of AccessOne further enhances future growth prospects, despite ongoing legal proceedings and general industry risks.

Positives

• Achieved net income of $0.7 million for the three months ended July 31, 2025, a substantial turnaround from a net loss of $18.0 million in the prior year.
• Reported a 15% increase in total revenue for both the three and six months ended July 31, 2025, demonstrating strong top-line growth.
• Adjusted EBITDA saw significant growth, increasing by 240% for the three months and 305% for the six months ended July 31, 2025, indicating improved operational efficiency.
• Free cash flow turned strongly positive, reaching $9.6 million for the three months and $17.1 million for the six months ended July 31, 2025, reflecting robust cash generation from operations.
• Growth in Average Number of Healthcare Services Clients (AHSCs) and Total Revenue per AHSC indicates successful client acquisition and expansion strategies.
• The acquisition of AccessOne is a strategic move expected to integrate well with existing products and enhance financing solutions for healthcare receivables.
• Maintained compliance with all covenants related to the Capital One Credit Facility as of July 31, 2025, ensuring financial stability and access to credit.

Negatives

• Still reported a net loss of $3.3 million for the six months ended July 31, 2025, despite significant improvement.
• Allowance for doubtful accounts increased to $2,654 thousand as of July 31, 2025, from $1,468 thousand as of January 31, 2025.
• Incurred legal and professional services expenses associated with 14 putative class action complaints related to a 2024 cybersecurity incident impacting the ConnectOnCall service.

Risks

• Operates in a highly competitive industry, including competition from Electronic Health Records (EHR) and Practice Management (PM) systems, which may offer similar services or make integration more costly.
• Failure to effectively manage future growth, both organic and through acquisitions, could strain business operations and hinder the implementation of business strategy.
• Operating results may fluctuate significantly due to factors like acquisition timing, market acceptance of products, new competitors, length of sales/implementation cycles, and changes in healthcare policy.
• Privacy concerns, cyber-attacks, data breaches, or cybersecurity incidents (like the 2024 ConnectOnCall incident) could lead to economic loss, reputational damage, legal penalties, and liability.
• Operations in India subject the company to additional risks, including legal/regulatory compliance, increasing wages, and political/economic instability.
• Significant upfront costs are incurred in client relationships, and failure to grow these relationships over time may prevent cost recovery and harm operating results.
• Variable sales and implementation cycles can lead to fluctuations in quarterly results and delays in revenue recognition.
• Estimates and assumptions for target market size may be inaccurate, and market growth may not translate to similar business growth rates.
• Dependence on senior management and key employees, with loss or inability to attract/retain skilled personnel adversely affecting the business.
• Acquisitions, including the pending AccessOne Acquisition, may be difficult to integrate, divert management resources, result in unanticipated costs, or dilute stockholders.
• Operating as a fully remote company presents unique operational risks, including potential cybersecurity vulnerabilities and impacts on corporate culture.
• Subject to complex healthcare laws and data privacy/security laws (HIPAA, CCPA, CPRA, My Health My Data Act, GDPR, PIPEDA, CASL), with non-compliance leading to fines, penalties, and reputational harm.
• Artificial intelligence (AI) presents risks such as security threats to confidential data, increased regulatory burden, and heightened competition.
• Reliance on third-party contractors, vendors, and partners (including those outside the U.S. and affected by geopolitical events like the Russian invasion of Ukraine) for critical services, with replacement being difficult and disruptive.
• Interruption or failure of information technology and communications systems (e.g., Change Healthcare cyber-attack in February 2024) could impair service delivery and harm operating results.
• Potential liability for use of incorrect or incomplete data provided to clients, which could harm business and reputation.
• Use of open source software could lead to litigation or requirements to disclose proprietary source code.
• Changes in laws and regulations relating to interchange fees on payment card transactions could adversely affect revenue and results of operations.
• Potential for additional government regulation, including FDA oversight, FCPA, economic sanctions, and export controls.
• Cash and cash equivalents could be adversely affected if financial institutions fail, especially balances exceeding FDIC insurance limits.
• Need to incur additional indebtedness or seek new equity/debt financings to support growth, which may not be available on acceptable terms or could dilute stockholders.
• Restrictive covenants in the Capital One Credit Facility may limit business strategies and ability to obtain additional capital.
• Adverse developments in the financial services industry could impact access to capital and liquidity.
• Stock price volatility and lack of intent to pay dividends may affect investor returns.

Future Outlook

The company anticipates continued growth, driven by its integrated SaaS-based software and payment platform. The pending acquisition of AccessOne is expected to enhance financing solutions for healthcare receivables and integrate well with existing products. The company believes its existing cash, cash generated from operations, and a new bridge loan facility will be sufficient to fund operations for at least the next 12 months. Management will continue to monitor the impact of macroeconomic and geopolitical developments on its business.

Management Comments

• "Phreesia's mission is to make care easier every day."
• "We believe the addition of AccessOne's platform is a natural progression that will integrate well with our existing products."

Industry Context

The healthcare industry is experiencing a significant shift towards digitalized record keeping and increasing patient responsibility and engagement. This trend drives demand for technology-enabled services that streamline patient intake, registration, and payments. The rapid evolution of AI technologies is both an opportunity for enhanced productivity and innovation, and a source of increased competition and regulatory scrutiny. Macroeconomic conditions, including inflation and interest rate environments, and geopolitical uncertainties continue to impact global financial markets and business operations, potentially affecting healthcare spending and client purchasing patterns.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• 14 putative class action complaints were filed against ConnectOnCall.com, LLC (a subsidiary acquired in October 2023) and Phreesia, Inc. in the United States District Court for the Eastern District of New York.
• The cases have been consolidated as In re ConnectOnCall.com Data Breach Litigation, alleging personally identifiable information and personal health information theft due to a 2024 cybersecurity incident.
• Plaintiffs seek monetary damages, disgorgement, restitution, attorneys' fees, interest, declaratory relief, and injunctive relief.
• The company expects to incur legal and professional services expenses, net of probable insurance recoveries, but cannot reasonably estimate a range of possible losses at this early stage of proceedings.

Related Party Transactions

• Recognized revenue totaling $273 thousand for the three months and $461 thousand for the six months ended July 31, 2025, from advertisements placed by a pharmaceutical company.
• One of the company's independent board members also serves on the board of directors for this pharmaceutical company.
• Accounts receivable from this pharmaceutical company totaled $116 thousand as of July 31, 2025.

Stakeholder Impact

• Shareholders: Potential for increased stock value due to strong financial performance and strategic acquisition, but also face risks from stock price volatility, no current dividends, and potential dilution from future capital raises.
• Employees: Continued investment in growth and new solutions may create opportunities, but remote work environment poses unique operational and cybersecurity risks. Stock-based compensation remains a significant component of total compensation.
• Customers (Healthcare Services Clients): Benefit from enhanced solutions and potential integration with AccessOne's financing, but face risks related to service interruptions, data security, and the company's ability to manage rapid growth and timely implementations.
• Customers (Life Sciences Companies): Benefit from increased patient outreach capabilities through an expanding healthcare services client base, but revenue is sensitive to new drug approvals and market success.
• Suppliers and Partners: Continued reliance on third-party contractors and vendors, including those in geopolitically unstable regions, creates supply chain and operational risks. Cybersecurity incidents affecting partners (e.g., Change Healthcare) can disrupt services.
• Creditors: The company's compliance with debt covenants and access to a bridge loan facility for the AccessOne acquisition indicate a stable relationship, but future indebtedness could introduce additional restrictive covenants.

Next Steps

• Close the AccessOne Acquisition, expected during the third quarter or early fourth quarter of fiscal year 2026, subject to customary closing conditions and regulatory approvals.
• Perform further analysis through year-end on the estimated impact of the One Big Beautiful Bill Act (OBBBA) on tax provisions.
• Continue to invest in business growth, develop new solutions, enhance existing solutions and services, and improve operating infrastructure.
• Monitor macroeconomic and geopolitical developments and their potential impact on the business and financial condition.
• Evaluate the impact of new accounting pronouncements (ASU 2023-09, ASU 2024-03, ASU 2025-01, ASU 2025-05) on financial statements and disclosures.

Key Dates

Recommendation

The company has demonstrated a significant financial turnaround, moving from substantial losses to quarterly net income and robust free cash flow generation. The 15% revenue growth across all segments, coupled with a dramatic increase in Adjusted EBITDA, indicates strong operational execution and market demand for its solutions. The strategic acquisition of AccessOne is a well-aligned move to expand its offerings in healthcare financing, further strengthening its competitive position. While risks such as cybersecurity litigation and competitive pressures exist, the overall financial performance and strategic direction presented in this filing suggest a compelling investment opportunity with strong upside potential.

Keywords

Healthcare Technology, SaaS, Patient Engagement, Payment Processing, SEC Filing, 10-Q, Financial Results, Adjusted EBITDA, Free Cash Flow, AccessOne Acquisition, Cybersecurity, Data Privacy, Healthcare Regulations, Artificial Intelligence, PHR